Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells. [electronic resource]
Producer: 20121221Description: 758-68 p. digitalISSN:- 1873-4596
- Antineoplastic Agents -- pharmacology
- Antioxidant Response Elements
- Arsenic Trioxide
- Arsenicals -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Differentiation
- Cell Line, Tumor -- drug effects
- Cell Survival -- drug effects
- Doxorubicin -- pharmacology
- Drug Resistance, Neoplasm
- Etoposide -- pharmacology
- Gene Expression Regulation -- drug effects
- Gene Knockdown Techniques
- Glutamate-Cysteine Ligase -- genetics
- Heme Oxygenase-1 -- genetics
- Humans
- Intracellular Signaling Peptides and Proteins -- genetics
- Kelch-Like ECH-Associated Protein 1
- Lung Neoplasms -- drug therapy
- Models, Biological
- NAD(P)H Dehydrogenase (Quinone) -- genetics
- NF-E2-Related Factor 2 -- genetics
- Neoplastic Stem Cells -- metabolism
- Oxides -- pharmacology
- PPAR gamma -- agonists
- Proto-Oncogene Mas
- RNA Interference
- Rosiglitazone
- Thiazolidinediones -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.